サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：気道管理デバイスの世界市場-2023年～2030年
市場調査レポート
商品コード
1352117

気道管理デバイスの世界市場-2023年～2030年

Global Airway Management Devices Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
気道管理デバイスの世界市場-2023年～2030年
出版日: 2023年09月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

気道管理は、単純な窒息から複雑な気道閉塞まで、さまざまな状況で必要とされることがあります。気道閉塞は、舌や異物が気道をふさいだ結果として起こることが最も多いです。また、気道の損傷、血液や分泌物（唾液や粘液など）の増加、気道の炎症が原因となることもあります。

さらに、気道管理デバイス市場は、呼吸器疾患の有病率の上昇、手術件数の増加に伴う麻酔の使用量の増加、医療費の増加、医療インフラの進歩、ケア提供の拡大に対する需要の高さなど、さまざまな要因によって牽引されており、これらすべてが気道管理デバイス市場に利益をもたらしています。

ダイナミクス

呼吸器疾患の有病率の上昇

呼吸器疾患の有病率の増加は、予測期間中に市場が成長するための重要な要因の1つです。呼吸器疾患の増加以来、気道管理デバイスの使用はしばしば急速に使用されており、これは実際に市場成長を増加させる。例えば、Centres for Disease Control and Prevention（疾病管理予防センター）によると、COPDは推定2億人が罹患し、毎年320万人が死亡しており、世界第3位の死亡原因となっています。

喘息は最も一般的な非感染性疾患のひとつで、世界で2億6,200万人が罹患しています。2022年には新たに220万人近くが肺がんに罹患し、180万人が死亡すると予想されており、肺がんは世界のがん死亡の4人に1人を占めています。下気道感染症または肺炎は顕著な死因であり、主に中低所得国（LMICs）において毎年240万人以上の死者を出しています。COVID-19は世界中で肺炎による死亡者数を大幅に増加させています。

気道管理における技術的に高度な機器の開発が増加

気道管理における技術的に先進的なデバイスの開拓の台頭は、気道管理デバイス市場が予測期間中に成長するための主な要因の1つです。

例えば、2022年1月、ICU Medical Inc.は、Smiths Group PLCからSmiths Medicalの買収を完了し、気道管理用デバイス、バイタルケア製品、外来輸液デバイスなどの製品ポートフォリオを世界的に拡大し、患者の治療経験を向上させ、全体的な転帰を改善しています。

償還政策の欠如

医療保険制度が貧弱なため、発展途上国では高価な気道管理デバイスの導入率が低いです。世界銀行グループによると、一人当たりの年間平均医療費は80米ドルであり、国民は慢性疾患やCOVID-19流行病にかかりやすくなっています。

国民皆保険のための財政不足は、最貧国54カ国の間で2030年までに1,760億米ドルに達すると予想されています。ビデオ喉頭鏡のような医療機器や高度な手術方法の採用が限られているため、気道管理デバイスの市場シェアは制限されています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 呼吸器疾患の有病率の上昇
      • 気道管理における技術的に高度な機器の開発が増加
    • 抑制要因
      • 償還政策の欠如
    • 機会
      • 新興諸国における成長可能性の上昇
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 COVID-19分析

第7章 タイプ別

  • 喉頭鏡
  • 声門下気道管理デバイス
  • 声門上気道管理デバイス
  • 蘇生器
  • 輪状咽頭切開キット
  • その他

第8章 年齢別

  • 小児/新生児
  • 成人

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
      • その他アジア太平洋
  • 中東・アフリカ
    • 地域別の主な動向

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Medtronic
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Boston Scientific Corporation
  • Olympus Corporation
  • ICU Medical, Inc
  • ConvaTec Group Plc
  • KARL STORZ
  • Teleflex Incorporated
  • Ambu A/S
  • Verathon Inc
  • SourceMark

第13章 付録

目次
Product Code: MD6868

Overview

Airway management may be required for individuals in a variety of circumstances, ranging from simple choking to complicated airway obstruction. Airway obstruction most commonly occurs as a result of the tongue or foreign bodies blocking the airway. It can also be the result of injury to the airway, increased presence of blood and secretions (e.g., saliva and mucus), or inflammation of the airway.

Futhermore, the airway management devices market is driven by various factors like rising prevalence of respiratory diseases, and as the number of surgeries increases, so does the use of anaesthesia, the increase in healthcare spending, advancements in healthcare infrastructure, and a high demand for expanded care delivery all benefit the airway management device market.

Dynamics

Rise in Prevalence of Respiratory Diseases

Increase prevalence of respiratory disease is one the key driver that helps the market to grow during forecast period. Since rise in respiratory diseases the use of airway managmenet devices are often used rapdily which indeed will increase the market growth. For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 million people, with 3.2 million dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 million people worldwide.With almost 2.2 million new instances of lung cancer expected in 2022 and 1.80 million fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 million fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Rise in Developing Technologically Advanced Devices in Airway Management

Rise in developing technologically advanced devices in airway management is one of the key driver that helps the airway management devices market to grow during the forecast period.

For instance, in January 2022, ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group PLC, to increase the product portfolio globally in devices for airway management, vital care products, ambulatory infusion devices, and others to enhance the patient treatment experience and improve overall outcomes.

Lack of Reimbursement Policies

Due to poor healthcare insurance programmes, developing nations have low adoption rates for pricey airway management devices. According to the World Bank Group, the average yearly healthcare expenditure is $80 per person, making the population more prone to chronic sickness and COVID-19 epidemics.

The financial shortfall for universal health care is anticipated to reach $176 billion by 2030 among the 54 poorest countries. The limited adoption of medical equipment such as video laryngoscopes and sophisticated surgical methods restricts the market share of airway management devices.

Segment Analysis

The global airway management devices is segmented based on type, age, end user and region.

The Laryngoscopes From Type Segment Accounted for Approximately 42.5 % of the Airway Management Devices Share

The laryngoscopes from type segment with around 42.5% is expected to dominate during the forecast period. Laryngoscopy is a visual examination using a throat scope to view the larynx, which contains vocal cords. It helps diagnose ear or throat pain, airway blockages, throat narrowing, and swallowing difficulties.

For instance, in April 2022 OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, launched new laryngoscope reference designs that include a range of OMNIVISION products that help improve patient care by providing crisp, clear images for single-use video laryngoscopes. Visualization makes insertion of the endotracheal tube easier and faster and avoids failures in difficult airways, significantly reducing the chances of complications and even death.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to the rising R&D and introduction of new technologies in devices of airway management by key players to help aid in patient treatment is likely to drive the North America market growth. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region also drive the this region in future.

For instance, on June 21, 2023 Teleflex Incorporated a leading global provider of medical technologies, announced a partnership with Shenzhen Insighters Medical Technology Co., Ltd. As the exclusive U.S. distributor of the Insighters Video Laryngoscope system, which is designed to inspect the upper glottic airway and facilitate endotracheal intubation.

Competitive Landscape

The major global players in the airway management devices market include: Medtronic , Boston Scientific Corporation , Olympus Corporation, ICU Medical, Inc, ConvaTec Group Plc, KARL STORZ, Teleflex Incorporated , Ambu A/S , Verathon Inc, SourceMark and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has increased the number of patients admitted to emergency departments and intensive care units. Patients suffering from severe infections typically have respiratory failure or low oxygen saturation, necessitating the use of positive air pressure devices such as ventilators. As a result, demand for airway control devices, particularly single-use devices, is increasing.

As non-invasive methods carry the potential of virus particle aerosolization, the number of patients requiring intubation via invasive airway management procedures has grown. Healthcare practitioners that provide airway management treatment to COVID-19 patients and other patients in healthcare institutions are putting themselves at danger, which has boosted the need for single-use devices.

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global airway management devices, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global airway management devices growth over the forecast period.

By Type

  • Laryngoscopes
  • Infraglottic Airway Management Devices
  • Supraglottic Airway Management Devices
  • Resuscitators
  • Cricothyrotomy Kits
  • Others

By Age

  • Pediatrics/Neonates
  • Adults

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In Jan 2022 Qure.ai, a health tech firm, received FDA approval for an artificial intelligence (AI) algorithm, qXR-BT, that helps doctors in assessing Breathing Tube (BT) placements. The algorithm helps clinicians locate the BT location and automate measurements for intubated patients using chest X-rays.
  • In May 2021, Medtronic introduced the SonarMed airway monitoring system, acoustic technology for real-time monitoring of endotracheal tube (ETT) obstruction and position in neonates and infants. This innovative device helps clinicians make informed decisions for life-saving care.
  • In May 2021, Olympus Corporation announced the FDA clearance of its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.

Why Purchase the Report?

  • To visualize the global airway management devices market segmentation based on type, age, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global airway management devices market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global airway management devices market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Age
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Prevalence of Respiratory Diseases
      • 4.1.1.2. Rise in Developing Technologically Advanced Devices in Airway Management
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Reimbursement Policies
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Growth Potential in Developing Countries
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Laryngoscopes *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Infraglottic Airway Management Devices
  • 7.4. Supraglottic Airway Management Devices
  • 7.5. Resuscitators
  • 7.6. Cricothyrotomy Kits
  • 7.7. Other

8. By Age

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 8.1.2. Market Attractiveness Index, By Age
  • 8.2. Pediatrics/Neonates*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Adults

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Spain
      • 10.3.6.5. Italy
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Boston Scientific Corporation
  • 12.3. Olympus Corporation
  • 12.4. ICU Medical, Inc
  • 12.5. ConvaTec Group Plc
  • 12.6. KARL STORZ
  • 12.7. Teleflex Incorporated
  • 12.8. Ambu A/S
  • 12.9. Verathon Inc
  • 12.10. SourceMark

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us